A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients
Quentin Binet(Cliniques Universitaires Saint-Luc), Nicolas Lanthier(Cliniques Universitaires Saint-Luc), Audrey Loumaye(Cliniques Universitaires Saint-Luc), Michel P. Hermans
Cited by 3
Related Papers
SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule
|Kidney International|2020|236
Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?
|Stem Cell Research & Therapy|2017|52
Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?
|Acta gastro-enterologica belgica|2022|31
Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
|Case Reports in Hematology|2017|29